Brief: EMA Says European Commission Withdraws Marketing Authorisation For Hirobriz Breezhaler On Oct 30, 2026
30/10/2026 17:07
BRIEF-EMA Says European Commission Withdraws Marketing Authorisation For Hirobriz Breezhaler On Oct 30, 2026 Oct 30 (Reuters) - EMA:
EMA - EUROPEAN COMMISSION WITHDRAWS MARKETING AUTHORISATION FOR HIROBRIZ BREEZHALER ON OCT 30, 2026
EMA - NOVARTIS EUROPHARM REQUESTS WITHDRAWAL OF HIROBRIZ BREEZHALER FOR COMMERCIAL REASONS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Novartis AG
See all newsSwiss pharma industry behind in technology and clinical trials, index shows
European shares rise as Democrats take US Congress, Novo Nordisk surges
European shares rise as Democratic sweep lifts clean energy, bank stocks
Europe set to open lower as Democratic sweep fuels AI regulation fears
Brief: Bioarctic Says Novartis Terminates Option, Collaboration And License Agreement With Bioarctic